Decentrialz logo
  • HIPAA Compliant
  • ISO 27001 Certified
Find Trials
About UsContact
Become a Volunteer+1 877 705 1914

Status:

COMPLETED

tDCS for Treatment Resistant Obsessive Compulsive Disorder

Lead Sponsor:

Centre Hospitalier Henri Laborit

Collaborating Sponsors:

Ministry of Health, France

Conditions:

Obsessive-Compulsive Disorder

Eligibility:

All Genders

18-70 years

Phase:

NA

Brief Summary

It's a multicentric, randomized, controlled study concerning 100 patients with treatment-resistant obsessive compulsive disorders (OCD). The aim of this study is to evaluate the effect of transcranial...

Eligibility Criteria

Inclusion

  • Meets criteria for obsessive compulsive disorder according to Diagnostic and Statistical Manual (DSM IV) with a "good insight" (BABS)
  • No current depressive and suicidal risks
  • No epileptic pathology
  • Age: Participants will be both males and females, 18-70 years of age included.
  • Chronic Obsessive compulsive disorder ( Total Y-BOCS\>20 or Y-BOCS one subscale \> 15)
  • Obsessive compulsive disorder resistant to pharmacology treatment :
  • at least 2 antidepressants (IRS type) (\> 12 weeks)
  • cognitive and comportment therapy since at least one year
  • Treatment stability (antidepressants) for more than 12 weeks without significant improvement.
  • Affiliation to a social security system (recipient or assignee),
  • Signed written inform consent form

Exclusion

  • Female subject who is pregnant, or of child-bearing age, sexually active and not using reliable contraception or who is nursing,
  • Patient under curators
  • Patient hospitalized under duress
  • Meets another diagnosis of axe 1 of DSM-IV
  • Current depressive or suicidal risks
  • Patient with any form of metal in the cranium, a pacemaker, skull defects, or skin lesions to the scalp (cuts, abrasions, rash)
  • Epileptic patient
  • Patient with a medical history of cranial trauma
  • Patient unable to give his or hers informed consent

Key Trial Info

Start Date :

November 3 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 24 2022

Estimated Enrollment :

83 Patients enrolled

Trial Details

Trial ID

NCT03304600

Start Date

November 3 2017

End Date

February 24 2022

Last Update

April 22 2022

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Hospices Civils De Lyon

Lyon, France

2

CHU de Nantes

Nantes, France, 44093

3

Centre Hospitalier Henri Laborit

Poitiers, France, 86021

4

C.H. Guillaume Regnier

Rennes, France, 35703